Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

Delayed Data
As of 1:29pm ET
 -0.0535 / -1.75%
Today’s Change
Today|||52-Week Range
Merrimack (MACK) Goes Uphill: Is a Turnaround Likely?
Jan 17 / Zacks.com - Paid Partner Content
Merrimack (MACK) Sells Onivyde Rights to Ipsen for $1B
Jan 09 / Zacks.com - Paid Partner Content
Is the Options Market Predicting a Spike in Merrimack (MACK) Stock?
Jan 11 / Zacks.com - Paid Partner Content
Here's Why Merrimack Pharmaceuticals Inc. Fell 47.3% in 2016
Jan 09 / MotleyFool.com - Paid Partner Content
Company News for January 10, 2017
Jan 10 / Zacks.com - Paid Partner Content
Why Merrimack Pharmaceuticals Stock Is Roaring Higher Today
Jan 09 / MotleyFool.com - Paid Partner Content